Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 2
2013 2
2014 1
2015 1
2016 5
2017 5
2018 3
2019 3
2020 2
2021 5
2022 8
2023 10
2024 9
2025 7
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement.
Bruno MK, Dhall R, Duquette A, Haq IU, Honig LS, Lamotte G, Mari Z, McFarland NR, Montaser-Kouhsari L, Rodriguez-Porcel F, Shurer J, Siddiqui J, Spears CC, Wills AA, Diaz K, Golbe LI; as the Diagnosis and Treatment Working Group, CurePSP Center of Care (CoC) Network. Bruno MK, et al. Among authors: rodriguez porcel f. Neurol Clin Pract. 2024 Dec;14(6):e200345. doi: 10.1212/CPJ.0000000000200345. Epub 2024 Aug 16. Neurol Clin Pract. 2024. PMID: 39185098 Free PMC article. Review.
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Furr Stimming E, Claassen DO, Kayson E, Goldstein J, Mehanna R, Zhang H, Liang GS, Haubenberger D; Huntington Study Group KINECT-HD Collaborators. Furr Stimming E, et al. Lancet Neurol. 2023 Jun;22(6):494-504. doi: 10.1016/S1474-4422(23)00127-8. Lancet Neurol. 2023. PMID: 37210099 Clinical Trial.
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis.
Chapleau M, La Joie R, Yong K, Agosta F, Allen IE, Apostolova L, Best J, Boon BDC, Crutch S, Filippi M, Fumagalli GG, Galimberti D, Graff-Radford J, Grinberg LT, Irwin DJ, Josephs KA, Mendez MF, Mendez PC, Migliaccio R, Miller ZA, Montembeault M, Murray ME, Nemes S, Pelak V, Perani D, Phillips J, Pijnenburg Y, Rogalski E, Schott JM, Seeley W, Sullivan AC, Spina S, Tanner J, Walker J, Whitwell JL, Wolk DA, Ossenkoppele R, Rabinovici GD; PCA International Work Group. Chapleau M, et al. Lancet Neurol. 2024 Feb;23(2):168-177. doi: 10.1016/S1474-4422(23)00414-3. Lancet Neurol. 2024. PMID: 38267189 Free PMC article.
Editorial: The many faces of brain aging.
Marsili L, Canevelli M, Rodriguez-Porcel F. Marsili L, et al. Among authors: rodriguez porcel f. Front Aging Neurosci. 2022 Aug 30;14:1018238. doi: 10.3389/fnagi.2022.1018238. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36110427 Free PMC article. No abstract available.
Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy.
Quattrone A, Franzmeier N, Huppertz HJ, Seneca N, Petzold GC, Spottke A, Levin J, Prudlo J, Düzel E; PASSPORT Study Group, the AL‐108‐231 Investigators, the Arise Investigators, the Tauros MRI Investigators, the DESCRIBE‐PSP group; Höglinger GU. Quattrone A, et al. Mov Disord. 2025 Nov;40(11):2517-2530. doi: 10.1002/mds.70026. Epub 2025 Aug 30. Mov Disord. 2025. PMID: 40884249 Free PMC article.
Neuropsychological test performance in mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis.
Wyman-Chick KA, Bayram E, Gravett S, D'Antonio F, Rodriguez-Porcel F, Kane JPM, Ferman TJ, Olson-Bullis BA, Boeve BF, Bonanni L, Ferreira D; Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) Lewy Body Dementias Professional Interest Area (LBD PIA) Prodromal Working Group. Wyman-Chick KA, et al. Among authors: rodriguez porcel f. Alzheimers Dement. 2025 Feb;21(2):e14450. doi: 10.1002/alz.14450. Epub 2025 Jan 10. Alzheimers Dement. 2025. PMID: 39791487 Free PMC article.
Brain Networks Route Neurodegeneration Patterns in Patients with Progressive Supranuclear Palsy.
Palleis C, Quattrone A, Dehsarvi A, Roemer-Cassiano SN, Bernhardt AM; AL‐108‐231 Investigators, the PASSPORT Study Group; Huppertz HJ, Malpetti M, Boxer AL, Gnörich J, Frontzkowski L, Levin J, Brendel M, Höglinger GU, Franzmeier N. Palleis C, et al. Mov Disord. 2025 Oct;40(10):2102-2115. doi: 10.1002/mds.30257. Epub 2025 Jun 9. Mov Disord. 2025. PMID: 40485628 Free PMC article.
Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations.
Rodriguez-Porcel F, Wyman-Chick KA, Abdelnour Ruiz C, Toledo JB, Ferreira D, Urwyler P, Weil RS, Kane J, Pilotto A, Rongve A, Boeve B, Taylor JP, McKeith I, Aarsland D, Lewis SJG; Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+. Rodriguez-Porcel F, et al. Transl Neurodegener. 2022 May 2;11(1):24. doi: 10.1186/s40035-022-00299-w. Transl Neurodegener. 2022. PMID: 35491418 Free PMC article. Review.
Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design.
Toledo JB, Abdelnour C, Weil RS, Ferreira D, Rodriguez-Porcel F, Pilotto A, Wyman-Chick KA, Grothe MJ, Kane JPM, Taylor A, Rongve A, Scholz S, Leverenz JB, Boeve BF, Aarsland D, McKeith IG, Lewis S, Leroi I, Taylor JP; ISTAART Lewy body dementias Trial Methods Working Group. Toledo JB, et al. Among authors: rodriguez porcel f. Alzheimers Dement. 2023 Jan;19(1):318-332. doi: 10.1002/alz.12814. Epub 2022 Oct 14. Alzheimers Dement. 2023. PMID: 36239924 Free PMC article. Review.
59 results